Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: NZ$0.02 M
• Last 3 months FTD volume: NZ$0.29 M
• Last year FTD volume: NZ$0.29 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	NZ$94.71 M	NZ$0.14 B	🇬🇧 UK
Sanofi SNY	NZ$1.53 M	NZ$65.43 M	🇫🇷 France
Biogen BIIB	NZ$36.5 M	NZ$84.81 M	🇺🇸 USA
AstraZeneca AZN	NZ$54.5 M	NZ$0.18 B	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	NZ$12.48 M	NZ$36.02 M	🇺🇸 USA
Sangamo Therapeutics SGMO	NZ$2.42 M	NZ$6.32 M	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$0.17 B	NZ$0.47 B	🇺🇸 USA